Related Experiment Video
Updated: Jan 27, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells
Hongfang Li1,2, Jing Wang1, Feixue Xu1
1Department of Gynecology, The First Hospital of Lanzhou University, Lanzhou, 730000, PR China.
Abstract:
Aim: Research on novel mutant genes may develop the treatment of cervical cancer (CC). The role of miRNA-526b in epithelial-mesenchymal transition (EMT) of CC was investigated. Methods: The role and the molecular mechanism of miRNA-526b in CC and its effect on EMT were analyzed in clinical specimens and oncology experiments. Results: miRNA-526b was proved to be decreased in CC and associated with malignant clinicopathological characters. The character of miRNA-526b in EMT was also inspected in CC cells and tumor models. miRNA-526b was found to be able to inhibit the EMT property of CC cells by directly targeting PBX3. Conclusion: miRNA-526b restoration may be deliberated as a new treatment strategy of CC.
Insights
MicroRNA-526b (miRNA-526b) is decreased in cervical cancer (CC) and inhibits its progression by targeting PBX3. Restoring miRNA-526b may offer a new treatment strategy for cervical cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical cancer (CC) remains a significant global health challenge.
- Novel therapeutic targets are crucial for improving CC treatment outcomes.
- Understanding the molecular mechanisms, including gene regulation, is key to developing new strategies.
Purpose of the Study:
- To investigate the role of microRNA-526b (miRNA-526b) in cervical cancer.
- To elucidate the molecular mechanism of miRNA-526b in regulating epithelial-mesenchymal transition (EMT) in CC.
- To assess the potential of miRNA-526b as a therapeutic agent for CC.
Main Methods:
- Analysis of clinical cervical cancer specimens.
- In vitro oncology experiments using CC cell lines.
- In vivo tumor model studies.
- Molecular mechanism investigation, including gene targeting analysis.
Main Results:
- miRNA-526b expression was found to be significantly decreased in cervical cancer tissues.
- Lower miRNA-526b levels correlated with advanced clinicopathological features of CC.
- miRNA-526b was demonstrated to inhibit EMT in CC cells by directly targeting PBX3.
- Restoration of miRNA-526b suppressed the EMT phenotype in CC cells and tumor models.
Conclusions:
- miRNA-526b plays a critical role in suppressing cervical cancer progression and metastasis.
- The inhibitory effect of miRNA-526b on EMT is mediated through direct targeting of PBX3.
- Restoration of miRNA-526b represents a promising novel therapeutic strategy for cervical cancer treatment.
Related Concept Videos
Phase Transitions
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Properties of Transition Metals
Mesenchymal Stem Cells
Phase Transitions: Vaporization and Condensation
Cooperative Allosteric Transitions

